Spineology has launched OptiMesh HA Nano, the company’s latest advancement in personalized spine care. The launch combines the company’s proprietary OptiMesh expandable interbody implant platform with Promimic AB’s patented HA Nano Surface technology.

OptiMesh HA Nano tech integrates a nano-thin hydroxyapatite (HA) surface treatment designed to create an ultra-hydrophilic absorption environment that supports cellular interaction at the bone-implant interface. The HA Nano surface promotes rapid cellular response and establishes a three-dimensional bioactive surface area, with the aim of accelerating osseointegration and reducing the risk of infection.

The surface technology has been demonstrated to enhance biological performance by encouraging stronger and faster bonding between bone and implant.

“This addition of the HA Nano technology to the OptiMesh portfolio underscores our continued commitment to innovation and patient-specific care,” said Brian Snider, CEO of Spineology. “The OptiMesh platform is uniquely built on our conform and expand implant technology that adapts to individual patient anatomy. Now, Spineology delivers a first-of-its-kind solution that integrates a well-studied surface treatment, optimized to support spinal fusion goals, and promote osseointegration.”

OptiMesh HA Nano is the first conformable, engineered mesh interbody implant platform to incorporate this nano-scale hydroxyapatite surface technology through a proprietary application process. This milestone reinforces Spineology’s commitment to advancing expandable implant technology through surface innovation designed to support lumbar interbody fusion procedures.